Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) has issued an update.
Sihuan Pharmaceutical Holdings Group Ltd. announced a share repurchase plan, buying back 16,174,000 shares at an average price of HK$0.6731 per share, totaling approximately HK$10.89 million. This move is part of the company’s strategy to enhance shareholder value and reflects its confidence in future growth. The company has seen significant progress in its medical aesthetics and innovative pharmaceuticals businesses, with a notable increase in revenue and the approval of new products. These developments are expected to positively impact the company’s revenue and profit, strengthening its position in the industry.
More about Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group Ltd., founded in 2001 and listed on the Main Board of the Stock Exchange in 2010, is an international medical aesthetics and biopharmaceutical company. It is driven by innovation with a strong research and development platform, a comprehensive product pipeline, and an efficient production and sales system. The company focuses on becoming a leading entity in China’s medical aesthetics and biopharmaceutical sectors.
YTD Price Performance: 146.94%
Average Trading Volume: 200
Technical Sentiment Signal: Sell
Current Market Cap: $793.8M
For a thorough assessment of 0460 stock, go to TipRanks’ Stock Analysis page.